The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon

被引:8
|
作者
Spillane, Cathy D. [1 ,2 ,3 ,4 ]
Cooke, Niamh M. [4 ,5 ]
Ward, Mark P. [1 ,2 ,3 ]
Kenny, Dermot [4 ,5 ]
Blackshields, Gordon [1 ,2 ,4 ]
Kelly, Tanya [1 ,2 ,3 ]
Bates, Mark [1 ,2 ,3 ]
Huang, Yanmei [1 ,2 ,3 ,6 ]
Martin, Cara [1 ,2 ,3 ]
Skehan, Sinead [1 ,2 ,3 ]
Canney, Aoife [1 ,2 ,3 ]
Gallagher, Michael [1 ,2 ,3 ]
Smyth, Paul [1 ,2 ]
Brady, Nathan [1 ,2 ,3 ]
Clarke, Andres [1 ,2 ,3 ]
Mohamed, Bashir [1 ,2 ,3 ]
Norris, Lucy [7 ,8 ]
Brooks, Doug A. [1 ,2 ,9 ]
Brooks, Robert D. [9 ]
Heatlie, Jessica K. [9 ]
Selemidis, Stavros [10 ]
Hanniffy, Sean [11 ]
Dixon, Eric [12 ]
Sheils, Orla [1 ,2 ,5 ]
O'Toole, Sharon A. [1 ,2 ,3 ,7 ,8 ]
O'Leary, John J. [1 ,2 ,5 ]
机构
[1] Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland
[2] Trinity St Jamess Canc Inst, Dublin, Ireland
[3] Coombe Women & Infants Univ Hosp, Emer Casey Mol Pathol Res Lab, Dublin, Ireland
[4] Dublin City Univ, Biomed Diagnost Inst, Dublin, Ireland
[5] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, 123 St Stephens Green, Dublin, Ireland
[6] Xinxiang Med Univ, Sch Forens Med, Xinxiang, Henan, Peoples R China
[7] Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland
[8] St James Hosp, Trinity Ctr Hlth Sci, Dublin, Ireland
[9] Univ South Australia, Canc Res Inst, Adelaide 5001, Australia
[10] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic 3083, Australia
[11] BD Res Ctr Ireland, Limerick, Ireland
[12] BD Technol & Innovat, Res Triangle Pk, NC USA
来源
TRANSLATIONAL ONCOLOGY | 2021年 / 14卷 / 12期
基金
爱尔兰科学基金会;
关键词
Cancer; Platelets; Metastasis; 5-gene panel; PAI-1; TUMOR-CELLS; GROWTH-FACTOR; BREAST-CANCER; METASTASIS; MEGAKARYOCYTES; TRANSITION; REACTIVITY;
D O I
10.1016/j.tranon.2021.101229
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumour metastasis accounts for over 90% of cancer related deaths. The platelet is a key blood component, which facilitates efficient metastasis. This study aimed to understand the molecular mechanisms involved in tumourplatelet cell interactions. The interaction between cancer cells and platelets was examined in 15 epithelial cell lines, representing 7 cancer types. Gene expression analysis of EMT-associated and cancer stemness genes was performed by RT-PCR. Whole transcriptome analysis (WTA) was performed using Affymetrix 2.0ST arrays on a platelet co-cultured ovarian model. Platelet adhesion and activation occurred across all tumour types. WTA identified increases in cellular movement, migration, invasion, adhesion, development, differentiation and inflammation genes and decreases in processes associated with cell death and survival following platelet interaction. Increased invasive capacity was also observed in a subset of cell lines. A cross-comparison with a platelet co-cultured mouse model identified 5 common altered genes; PAI-1, PLEK2, CD73, TNC, and SDPR. Platelet cancer cell interactions are a key factor in driving the pro-metastatic phenotype and appear to be mediated by 5 key genes which have established roles in metastasis. Targeting these metastasis mediators could improve cancer patient outcomes.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Mesenchymal stem cells derived microvesicles convey mesenchymal phenotype to recipient cells
    Kurbangaleeva, S.
    Kletukhina, S.
    Starostina, I.
    Rizvanov, A.
    Gomzikova, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 : 85 - 85
  • [32] Calcifications in prostate cancer: An active phenomenon mediated by epithelial cells with osteoblast-phenotype
    Scimeca, Manuel
    Bonfiglio, Rita
    Varone, Fabiana
    Ciuffa, Sara
    Mauriello, Alessandro
    Bonanno, Elena
    MICROSCOPY RESEARCH AND TECHNIQUE, 2018, 81 (07) : 745 - 748
  • [33] The Epithelial Mesenchymal Transition (EMT) Profile of Platelet Cloaked Cancer Cells.
    Crowley, D. J.
    Smyth, P. A.
    O'Toole, S. A.
    Egan, K.
    Kenny, D.
    Sheils, O. M.
    O'Leary, J. J.
    LABORATORY INVESTIGATION, 2011, 91 : 441A - 441A
  • [34] Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial
    Brady, Lauren
    Hayes, Brian
    Sheill, Grainne
    Baird, Anne-Marie
    Guinan, Emer
    Stanfill, Bryan
    Vlajnic, Tatjana
    Casey, Orla
    Murphy, Verena
    Greene, John
    Allott, Emma H.
    Hussey, Juliette
    Cahill, Fidelma
    Van Hemelrijck, Mieke
    Peat, Nicola
    Mucci, Lorelei
    Cunningham, Moya
    Grogan, Liam
    Lynch, Thomas
    Manecksha, Rustom P.
    McCaffrey, John
    O'Donnell, Dearbhaile
    Sheils, Orla
    O'Leary, John
    Rudman, Sarah
    McDermott, Ray
    Finn, Stephen
    PLOS ONE, 2020, 15 (12):
  • [35] Induction of neuronal-like phenotype in human mesenchymal stem cells by overexpression of Neurogeninl and treatment with neurotrophins
    Schaeck, Luisa
    Budde, Stefan
    Lenarz, Thomas
    Krettek, Christian
    Gross, Gerhard
    Windhagen, Henning
    Hoffmann, Andrea
    Warnecke, Athanasia
    TISSUE & CELL, 2016, 48 (05): : 524 - 532
  • [36] Adipose stromal cells promote the transition of colorectal cancer cells toward a mesenchymal-like phenotype
    Di Franco, Simone
    Stassi, Giorgio
    MOLECULAR & CELLULAR ONCOLOGY, 2021, 8 (05)
  • [37] A metastatic phenotype is reproduced in spheroids containing patient-specific cancer cells and mesenchymal stem cells
    Shvartsman, Dmitry
    Pepicelli, Amy
    Deems, Liam
    Deems, David
    Agoston, Elin S.
    Shahar, Amit
    CANCER RESEARCH, 2020, 80 (16)
  • [38] Induction of invasive phenotype by Casodex in hormone-sensitive prostate cancer cells
    Zhan, P
    Lee, ECY
    Packman, K
    Tenniswood, M
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 83 (1-5): : 101 - 111
  • [39] Induction of BRCAness phenotype by curcumin and hydroxyurea in WT BRCA ovarian cancer cells
    Mao, Yuehua
    Dinnen, Richard D.
    Fine, Robert L.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [40] Induction of BRCAness phenotype by curcumin and hydroxyurea in WT BRCA ovarian cancer cells
    Mao, Yuehua
    Dinnen, Richard D.
    Fine, Robert L.
    CANCER RESEARCH, 2014, 74 (19)